Popular Articles
Stretch Mark Cream

New XEOMIN(R) Is Now Available For The Treatment Of Blepharospasm, Cervical Dystonia And Post-Stroke Spasticity
Merz Pharma Canada Ltd. announces new XEOMIN® (Botulinum neurotoxin type A) is now available for prescribing to patients with the following serious, debilitating neuromuscular conditions:
generic viagra online
More Effective Cancer Treatment And The Migration Of Modern Man From Africa To Western Eurasia
The Collaborative Research Centre 806 "Unser Weg nach Europa: Kultur-Umwelt-Interaktion und menschliche Mobilität im Späten Quartär" (Our Road to Europe: Culture-Environment-Interaction and human Mobility in the late Quaternary) will be directed by Professor Dr. JÃørgen of the Department of Pre- and Protohistoric Archaeology. This research centre is looking at the mobility of populations in the last 190,000 years. The focus of research will be the journey of modern man from Africa to Western Eurasia and Europe, in particular. Migration processes, and the exchange of ideas, technology and culture that entails, are an important prerequisite for important developments. The centre"s main aim is to research, using scientific and archaeological methods, how human behaviour, the climate and the environment influenced important population movements. The scientists particularly want to examine the impacts that these factors have had on the actions and reactions of populations such as emigration, immigration and adaptation to new environments. Other universities and institutions are also involved the project. These include: the University of Bonn; RWTH Aachen University; Heidelberg University; the University of Duisburg-Essen as well as the Rhineland Regional Council; the Rheinisches Amt fÃør Bodendenkmalpflege (Rheinland Department for the Preservation and Care of Field Monuments) as well as the Neanderthal Museum in Mettmann. Drugshop to buy zoloft online and other pills.
News of the day
From Molecular Physiology To Therapeutic Applications Of Stem Cells
Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson"s disease to paralysis. Totipotent embryonic stem cells have great potential for generating a wide range of different human cells that can be used to restore malfunctioning or damaged cells and tissues in patients. Recent studies have shown that pluripotent stem cells derived from adult bone marrow, the umbilical cord and the placenta could also be induced to differentiate into a variety of different tissues. In this issue, we have invited several scientists in China to summarize their pioneering works in the stem cell research field.
Endocrinology

Study Shows Decreased Risk Of Death From Opportunistic Infections With Earlier Antiretroviral Treatment

HIV-positive people with opportunistic infections who receive earlier antiretroviral treatment lower their risk of death compared with people who delay treatment, according to a new study conducted by the Stanford University School of Medicine and published in PLoS One, the San Jose Mercury News reports. The findings could lead to changes in recommendations for antiretroviral treatment protocol, specifically for patients diagnosed with HIV at an advanced stage, the Mercury News reports. The study included 262 HIV-positive participants at 39 health care sites across the U.S., and 20 participants in South Africa. During the yearlong study, the researchers found that among the participants who were treated promptly after developing an opportunistic infection, 14% died or developed another infection. The researchers also found that 24% of participants who deferred treatment for an average of 45 days died or had a decrease in health outcomes. According to the Mercury News, the question of when to start HIV-positive people on antiretroviral treatment remains unclear because of issues such as the high cost of medicines, side effects, and drug interactions or resistance. Andrew Zolopa, head of Stanford University School of Medicine"s division of infectious diseases and lead investigator of the study, said that physicians often treat HIV-positive people for an "acute crisis, then follow up later with treatment for HIV." He continues, "But that answer is wrong. The study shows very clearly that there is no safety downside to doing this -- and the benefit is quite substantial, reducing death by 50%." "Even in San Francisco, one of the first epicenters of HIV in the United States, we still find that many people present late in the course of their illness with an opportunistic infection," Mitch Katz, director of San Francisco"s Department of Health who was not involved in the study, said. He added, "This study shows that it is lifesaving to treat those persons with antiretroviral drugs while they are still in the hospital." Katz said that the results could lead to changes in HIV/AIDS practices worldwide. The International AIDS Society, CDC and the British AIDS Society have developed guidelines recommending that early antiretroviral treatment be considered in patients with opportunistic infections, Zolopa said. In addition, NIH is considering an international study to examine earlier initiation of antiretroviral treatment involving more than 9,000 people from both developed and developing countries (Krieger, San Jose Mercury News, 5/15). The study is available online. Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):